FOLD

NASDAQ · Biotechnology

Amicus Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$14.41

-0.01 (-0.07%)

As of Mar 24, 9:55 PM ET ·

Analyst Consensus

Hold

Analysts

Moderate

Coverage

Buy 6 43%

Hold 8 57%

Sell 0 0%

Price Target

Analyst Price Target +623.5% upside

Low Target $68.91

Average Target $104.26

High Target $125.13

Current Price $14.41

Current
$14.41

Target
$104.26

$68.91 $104.26 avg $125.13

Scenario Analysis

Bear Case

$68.91

378.2%

Low target

Base Case

$104.26

+623.5%

Avg target

Bull Case

$125.13

+768.4%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$14.38

0.2% from high

52-Week Low

$5.51

+161.5% from low

50-Day SMA

$13.59

+6.0% vs SMA

200-Day SMA

$8.96

+60.8% vs SMA

RSI (14)

72.2

Overbought

Target vs 52W High

$104.26

+625.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+25.5%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.2%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-66.8%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	+3.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-26.5%